Results 171 to 179 of about 16,929 (179)
Some of the next articles are maybe not open access.
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
New England Journal of Medicine, 2019Vlado Perkovic +2 more
exaly
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
New England Journal of Medicine, 2019Itamar Raz, Marc P Bonaca, Ofri Mosenzon
exaly
SGLT2 inhibition — a novel strategy for diabetes treatment
Nature Reviews Drug Discovery, 2010exaly

